EP3318258

COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    14.3.2014
  • EP published:
    13.5.2020
  • EP application number:
    17189252.4
  • Max expiry date:
    13.3.2034
  • Title:
    COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS

Timeline

Today
14.3.2014EP application
13.5.2020EP Publication

Owner

  • Name:
    AbbVie Inc.
  • Address:
    1 North Waukegan Road, North Chicago, IL 60064, US

Inventor

  • Name:
    BERNSTEIN, Barry M.
  • Address:
    Mequon, WI 53092, US
  • Name:
    DUTTA, Sandeep
  • Address:
    Lincolnshire, IL 60069, US
  • Name:
    LIU, Wei
  • Address:
    Mundelein, IL 60060, US
  • Name:
    PODSADECKI, Thomas J.
  • Address:
    Northbrook, IL 60062, US
  • Name:
    CAMPBELL, Andrew L.
  • Address:
    Lake Forest, IL 60045, US
  • Name:
    MENON, Rajeev M.
  • Address:
    Buffalo Grove, IL 60089, US
  • Name:
    LIN, Chih-Wei
  • Address:
    Vernon Hills, IL 60061, US
  • Name:
    WANG, Tianli
  • Address:
    Lake Bluff, IL 60044, US
  • Name:
    AWNI, Walid M.
  • Address:
    Green Oaks, IL 60048, US
  • Name:
    MENSING, Sven
  • Address:
    68305 Mannheim, DE

Priority

  • Number:
    201361783437 P
  • Date:
    14.3.2013
  • Country:
    US

Classification

  • Categories:
    A61K 31/454, A61K 31/4985, A61K 31/7056, A61K 45/06, A61P 31/22

Upload documents